BIO-UV Group S.A. (EPA:ALTUV)

BIO-UV Group Statistics

Total Valuation

BIO-UV Group has a market cap or net worth of EUR 22.09 million. The enterprise value is 33.84 million.

Market Cap	22.09M
Enterprise Value	33.84M

Important Dates

The next estimated earnings date is Friday, December 19, 2025.

Earnings Date	Dec 19, 2025
Ex-Dividend Date	n/a

Share Statistics

BIO-UV Group has 13.88 million shares outstanding. The number of shares has increased by 20.44% in one year.

Current Share Class	13.88M
Shares Outstanding	13.88M
Shares Change (YoY)	+20.44%
Shares Change (QoQ)	+30.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.81%
Float	n/a

Valuation Ratios

The trailing PE ratio is 19.13.

PE Ratio	19.13
Forward PE	n/a
PS Ratio	0.59
PB Ratio	0.53
P/TBV Ratio	2.48
P/FCF Ratio	8.04
P/OCF Ratio	4.63
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.91, with an EV/FCF ratio of 12.32.

EV / Earnings	33.95
EV / Sales	0.91
EV / EBITDA	11.91
EV / EBIT	15.09
EV / FCF	12.32

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.51.

Current Ratio	2.05
Quick Ratio	1.17
Debt / Equity	0.51
Debt / EBITDA	7.43
Debt / FCF	7.69
Interest Coverage	2.79

Financial Efficiency

Return on equity (ROE) is 2.68% and return on invested capital (ROIC) is 2.32%.

Return on Equity (ROE)	2.68%
Return on Assets (ROA)	1.97%
Return on Invested Capital (ROIC)	2.32%
Return on Capital Employed (ROCE)	3.87%
Revenue Per Employee	253,156
Profits Per Employee	6,781
Employee Count	149
Asset Turnover	0.52
Inventory Turnover	1.13

Taxes

In the past 12 months, BIO-UV Group has paid 308,285 in taxes.

Income Tax	308,285
Effective Tax Rate	23.62%

Stock Price Statistics

The stock price has decreased by -14.41% in the last 52 weeks. The beta is 0.32, so BIO-UV Group's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-14.41%
50-Day Moving Average	1.63
200-Day Moving Average	1.83
Relative Strength Index (RSI)	47.17
Average Volume (20 Days)	23,040

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIO-UV Group had revenue of EUR 37.21 million and earned 996,767 in profits. Earnings per share was 0.08.

Revenue	37.21M
Gross Profit	23.29M
Operating Income	2.24M
Pretax Income	1.31M
Net Income	996,767
EBITDA	2.84M
EBIT	2.24M
Earnings Per Share (EPS)	0.08

Balance Sheet

The company has 9.36 million in cash and 21.11 million in debt, giving a net cash position of -11.75 million or -0.85 per share.

Cash & Cash Equivalents	9.36M
Total Debt	21.11M
Net Cash	-11.75M
Net Cash Per Share	-0.85
Equity (Book Value)	41.39M
Book Value Per Share	2.98
Working Capital	16.09M

Cash Flow

In the last 12 months, operating cash flow was 4.77 million and capital expenditures -2.02 million, giving a free cash flow of 2.75 million.

Operating Cash Flow	4.77M
Capital Expenditures	-2.02M
Free Cash Flow	2.75M
FCF Per Share	0.20

Margins

Gross margin is 62.59%, with operating and profit margins of 6.03% and 2.68%.

Gross Margin	62.59%
Operating Margin	6.03%
Pretax Margin	3.51%
Profit Margin	2.68%
EBITDA Margin	7.64%
EBIT Margin	6.03%
FCF Margin	7.38%

Dividends & Yields

BIO-UV Group does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.44%
Shareholder Yield	-20.44%
Earnings Yield	4.51%
FCF Yield	12.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIO-UV Group has an Altman Z-Score of 1.32 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.32
Piotroski F-Score	7